REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Status: Recruiting
Location: See all (54) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 105
Healthy Volunteers: f
View:
• BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR
Locations
United States
Alabama
University of Alabama at Birmingham
RECRUITING
Birmingham
Arizona
Abrazo Arizona Heart Hospital
RECRUITING
Phoenix
California
Kaiser Permanente Los Angeles Medical Center
RECRUITING
Los Angeles
Kaiser Permanente Northern California
RECRUITING
Sacramento
Sutter Heatlh
RECRUITING
Sacramento
Stanford Hospital & Clinics
RECRUITING
Stanford
Los Robles Regional Medical Center
RECRUITING
Thousand Oaks
Connecticut
Hartford Hospital
RECRUITING
Hartford
Yale New Haven Hospital
RECRUITING
New Haven
Washington, D.c.
MedStar Washington Medical Center
RECRUITING
Washington D.c.
Florida
Morton Plant Hospital
RECRUITING
Clearwater
HealthPark Medical Center, Lee Memorial Health
RECRUITING
Fort Myers
Orlando Health/Orlando Regional Medical Center
RECRUITING
Orlando
Iowa
MercyOne Iowa Heart Center
RECRUITING
Des Moines
Indiana
Parkview Health
RECRUITING
Fort Wayne
Massachusetts
Brigham and Women's Hospital
RECRUITING
Boston
Massachusetts General Hospital
RECRUITING
Boston
Maryland
Medstar Union Memorial Hospital
RECRUITING
Baltimore
Maine
Maine Medical Center
RECRUITING
Portland
Michigan
University of Michigan Health
RECRUITING
Ann Arbor
Henry Ford Hospital
RECRUITING
Detroit
Corewell Health (Spectrum)
RECRUITING
Grand Rapids
Minnesota
Abbott Northwestern/Minneapolis Heart
RECRUITING
Minneapolis
Mayo Clinic
RECRUITING
Rochester
CentraCare Heart and Vascular Center
RECRUITING
Saint Cloud
Montana
Providence Saint Patrick Hospital
RECRUITING
Missoula
North Carolina
Astrium Health Wake Forest Baptist Medical Center
RECRUITING
Winston-salem
New Hampshire
Dartmouth-Hitchcock Medical Center
RECRUITING
Lebanon
New Jersey
The Valley Hospital
RECRUITING
Paramus
New York
Buffalo General Medical Center
RECRUITING
Buffalo
Northwell Health
RECRUITING
Manhasset
Mount Sinai Hospital
RECRUITING
New York
NYU Langone Medical Center
RECRUITING
New York
Saint Francis Hospital
RECRUITING
Roslyn
Montefiore Medical Center
RECRUITING
The Bronx
Ohio
The Christ Hospital
RECRUITING
Cincinnati
University Hospitals of Cleveland Medical Center
RECRUITING
Cleveland
Oklahoma
Oklahoma Heart Hospital
RECRUITING
Oklahoma City
Oregon
Providence Saint Vincent Medical Center
RECRUITING
Portland
Pennsylvania
Lehigh Valley Hospital
RECRUITING
Allentown
UPMC Pinnacle
RECRUITING
Mechanicsburg
Allegheny General Hospital
RECRUITING
Pittsburgh
Lankenau Medical Center
RECRUITING
Wynnewood
Texas
Heart Hospital of Austin
RECRUITING
Austin
Houston Methodist Hospital
RECRUITING
Houston
University of Texas Health Science Center at Houston
RECRUITING
Houston
Methodist Hospital
RECRUITING
San Antonio
Virginia
University of Virginia Medical Center
RECRUITING
Charlottesville
Inova Fairfax Hospital
RECRUITING
Falls Church
Sentara Norfolk General Hospital
RECRUITING
Norfolk
Vermont
University of Vermont Medical Center
RECRUITING
Burlington
Washington
Providence Heart Institute (Providence Sacred Heart)
RECRUITING
Spokane
Wisconsin
Aurora St. Lukes Medical Center
RECRUITING
Milwaukee
Froedtert Hospital
RECRUITING
Milwaukee
Contact Information
Primary
RESTORE Study Clinical Team
RS.RESTORESTUDY@medtronic.com
763 514 4000
Time Frame
Start Date: 2025-02-06
Estimated Completion Date: 2033-07
Participants
Target number of participants: 225
Treatments
Medtronic Transcatheter Aortic Valves (TAV) or Edwards Transcatheter Aortic Valves (TAV)
Subjects will receive either a Medtronic TAV or Edwards TAV
Related Therapeutic Areas
Sponsors
Leads: Medtronic Cardiovascular